Fig. 3: Expression of SAMHD1 in AML blasts in the groups of patients that achieved CR/CRi or not. | Blood Cancer Journal

Fig. 3: Expression of SAMHD1 in AML blasts in the groups of patients that achieved CR/CRi or not.

From: Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens

Fig. 3

The black lines indicate the mean percentage of SAMHD1 positive AML blasts. a All patients; b patients that received HDAC consolidation therapy; c patients that received ara-C-containing induction therapy

Back to article page